Leap Therapeutics Inc. buy Raymond James
Start price
14.11.23
/
50%
€1.37
Target price
14.11.24
€16.21
Performance (%)
110.22%
Price
25.04.24
€2.98
Summary
This prediction is currently active. The BUY prediction by Raymond_James for Leap Therapeutics Inc. has seen massive gains of 110.22%. This prediction currently runs until 14.11.24. The prediction end date can be changed by Raymond_James at any time. Raymond_James has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Leap Therapeutics Inc. | 12.879% | 12.879% |
| iShares Core DAX® | -1.370% | -3.231% |
| iShares Nasdaq 100 | 0.172% | -3.339% |
| iShares Nikkei 225® | -0.801% | -7.859% |
| iShares S&P 500 | -0.369% | -2.979% |
Comments by Raymond_James for this prediction
In the thread Leap Therapeutics Inc diskutieren
Leap Therapeutics, Inc. (NASDAQ: LPTX) had its price target lowered by analysts at Raymond James from $18.50 to $17.50. They now have an "outperform" rating on the stock.
Ratings data for LPTX provided by MarketBeat